UNITY Biotechnology, Inc. to Announce Third Quarter 2018 Financial Results

SAN FRANCISCO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, plans to report results for the third quarter ended September 30, 2018, on Wednesday, November 7, 2018, after NASDAQ market close.

UNITY will not conduct a conference call in conjunction with the financial results press release.

About UNITY
UNITY Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter.

Investors
Endurance Advisors
Elizabeth Broder
ebroder@enduranceadvisors.com

Media
Austine Graff
UNITY Biotechnology
707-593-6151
austine.graff@unitybiotechnology.com

You just read:

UNITY Biotechnology, Inc. to Announce Third Quarter 2018 Financial Results

Distribution channels: Conferences & Trade Fairs

EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.